Buy One Get One free -Llimited Time Offer X
Relmisart A is a prescription medicine that is available as a Tablet. Relmisart A also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Relmisart A. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Relmisart A include Headache, Dizziness, Palpitations (fluttering in chest). While these are the most often observed Relmisart A side effects, there are can be others also. These have been listed below. Such side effects of Relmisart A normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Relmisart A has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Relmisart A's effects on the liver, heart and kidney are discussed below in the Relmisart A related warnings section.
Relmisart A can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Relmisart A in conditions like Congestive Heart Failure (CHF), Coronary Artery Disease (CAD), Angioedema.
Drug reaction of Relmisart A with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Relmisart A is not safe while driving, and is not addiction.
Relmisart A is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Relmisart A is used -
Severe
Common
Is the use of Relmisart A safe for pregnant women?
Relmisart A has many dangerous side effects in pregnant women. If you are pregnant, do not consume Relmisart A without medical advice.
Is the use of Relmisart A safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Relmisart A. It should only be taken after medical advice.
What is the effect of Relmisart A on the Kidneys?
Relmisart A may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Relmisart A on the Liver?
Relmisart A may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Relmisart A on the Heart?
The heart can be affected by Relmisart A. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Relmisart A should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Relmisart A unless your doctor advises you to do so -
Is this Relmisart A habit forming or addictive?
Forming a habit of Relmisart A has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Relmisart A can make you feel drowsy.
Is it safe?
Yes, but take Relmisart A only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Relmisart A for mental disorders.
Interaction between Food and Relmisart A
There is no information on the effects of taking Relmisart A with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Relmisart A
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Relmisart A.
Relmisart A can be taken as long as it is prescribed by your doctor. You must not discontinue taking it even when you start feeling well. In addition, you must not take it more frequently as that can have adverse effects. Follow the recommendations of your doctor completely.
Relmisart A is available in the form of tablets. A tablet is usually taken once a day, with or without food because food affects the absorption of this drug. It should be taken at exactly the same time every time to avoid skipping the dose. Relmisart A might start showing the effects between 2 to 4 weeks, therefore, it is important to continue taking it even when you feel well. One should take Relmisart A exactly as prescribed by their doctor.
No, Relmisart A is not a beta blocker/calcium channel blocker/diuretic/blood thinner/ace inhibitor. It is angiotensin II receptor blocker (an antihypertensive drug).
Yes, it is safe to take Relmisart A as long as it is prescribed by your doctor. However, in some people, it may cause some side effects like back pain, sinusitis, and diaarhea.
No, Relmisart A is not bad for kidneys. In fact, it protects the kidneys, thus, it is suitable for people with diabetes and mild-to-moderate kidney disease.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148